Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gianmario Candore

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Pharmacoepidemiology and Drug Safety|November 17, 2017
An algorithm to detect unexpected increases in frequency of reports of adverse events in EudraVigilanceLuis C Pinheiro, Gianmario Candore, Cosimo Zaccaria, et al.
Clinical Pharmacology and Therapeutics|January 21, 2020
Can We Rely on Results From IQVIA Medical Research Data UK Converted to the Observational Medical Outcome Partnership Common Data Model?: A Validation Study Based on Prescribing Codeine in ChildrenGianmario Candore, Karin Hedenmalm, Jim Slattery, et al.
Drug Safety|July 17, 2021
Is There an Increased Risk of Hepatotoxicity with Metamizole? A Comparative Cohort Study in Incident UsersKarin Hedenmalm, Alexandra Pacurariu, Jim Slattery, et al.
British Journal of Clinical Pharmacology|April 28, 2022
Ondansetron use in nausea and vomiting during pregnancy: A descriptive analysis of prescription patterns and patient characteristics in UK general practiceJim Slattery, Chantal Quinten, Gianmario Candore, et al.
Drug Safety|April 19, 2017
Patient Reporting in the EU: Analysis of EudraVigilance DataMarin Banovac, Gianmario Candore, Jim Slattery, et al.
Drug Safety|December 9, 2021
The Impact of Mandatory Reporting of Non-Serious Safety Reports to EudraVigilance on the Detection of Adverse ReactionsGianmario Candore, Sebastian Monzon, Jim Slattery, et al.
Drug Safety|April 23, 2015
Comparison of statistical signal detection methods within and across spontaneous reporting databasesGianmario Candore, Kristina Juhlin, Katrin Manlik, et al.
Drug Safety|April 9, 2024
Lessons Learned on Observed-to-Expected Analysis Using Spontaneous Reports During Mass VaccinationMaría Gordillo-Marañón, Gianmario Candore, Karin Hedenmalm, et al.
Drug Safety|March 10, 2018
EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health ProtectionRodrigo Postigo, Sabine Brosch, Jim Slattery, et al.
Drug Safety|January 11, 2016
Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous DatabasesSuzie Seabroke, Gianmario Candore, Kristina Juhlin, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Pharmacoepidemiology and Drug Safety|November 17, 2017
An algorithm to detect unexpected increases in frequency of reports of adverse events in EudraVigilanceLuis C Pinheiro, Gianmario Candore, Cosimo Zaccaria, et al.
Clinical Pharmacology and Therapeutics|January 21, 2020
Can We Rely on Results From IQVIA Medical Research Data UK Converted to the Observational Medical Outcome Partnership Common Data Model?: A Validation Study Based on Prescribing Codeine in ChildrenGianmario Candore, Karin Hedenmalm, Jim Slattery, et al.
Drug Safety|July 17, 2021
Is There an Increased Risk of Hepatotoxicity with Metamizole? A Comparative Cohort Study in Incident UsersKarin Hedenmalm, Alexandra Pacurariu, Jim Slattery, et al.
British Journal of Clinical Pharmacology|April 28, 2022
Ondansetron use in nausea and vomiting during pregnancy: A descriptive analysis of prescription patterns and patient characteristics in UK general practiceJim Slattery, Chantal Quinten, Gianmario Candore, et al.
Drug Safety|April 19, 2017
Patient Reporting in the EU: Analysis of EudraVigilance DataMarin Banovac, Gianmario Candore, Jim Slattery, et al.
Drug Safety|December 9, 2021
The Impact of Mandatory Reporting of Non-Serious Safety Reports to EudraVigilance on the Detection of Adverse ReactionsGianmario Candore, Sebastian Monzon, Jim Slattery, et al.
Drug Safety|April 23, 2015
Comparison of statistical signal detection methods within and across spontaneous reporting databasesGianmario Candore, Kristina Juhlin, Katrin Manlik, et al.
Drug Safety|April 9, 2024
Lessons Learned on Observed-to-Expected Analysis Using Spontaneous Reports During Mass VaccinationMaría Gordillo-Marañón, Gianmario Candore, Karin Hedenmalm, et al.
Drug Safety|March 10, 2018
EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health ProtectionRodrigo Postigo, Sabine Brosch, Jim Slattery, et al.
Drug Safety|January 11, 2016
Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous DatabasesSuzie Seabroke, Gianmario Candore, Kristina Juhlin, et al.
Pageof 3